Illumina, Inc. (NASDAQ ... delivering the NovaSeq X single-flow-cell system alongside a cutting-edge software upgrade and new kits.

Illumina is teaming up with Tempus AI for a project aimed at promoting the use of DNA sequencing tests across all major areas ...

The Global Single Cell Analysis Market achieved a valuation of $4.90 Billion in 2024 and is anticipated to exceed $21.97 ...

(RTTNews) - Illumina Inc. (ILMN) and Tempus AI, Inc. (TEM), Tuesday announced a collaboration to accelerate clinical adoption of next-generation sequencing tests through novel evidence generation.

In a case that had been closely watched across multiple industries, Illumina chose to divest Grail in the light of legal action from the European Commission and the US Federal Trade Commission.

Illumina Inc. (NASDAQ: ILMN) and Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a collaboration to ...

Researchers have developed a pioneering, sustainable method for producing cadmium-based quantum dots (QDs) in water using a biocompatible chalcogen source. This fully aqueous, continuous flow process ...

Wales has extended a scheme to harness the power of genomics to improve cancer care and prevention via an alliance with gene-sequencing giant Illumina ... from fragments of cell-free DNA (cfDNA ...

Genomic testing market was valued at US$ 14.51 billion in 2023 and is projected to attain a valuation of US$ 32.95 billion by 2032, at a CAGR of 9.54% during the forecast period, 2024-2032.

Shear flow systems can reveal in vivo-like changes in cell growth, adhesion and movement not observed in static assays, effectively emulating in vivo conditions and revealing true biology. In this ...